* agilon health inc AGL.N reported a quarterly adjusted
loss
of 29 cents per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -8 cents. The mean expectation of nineteen analysts for
the quarter was for a loss of 11 cents per share. Wall Street
expected results to range from -13 cents to -7 cents per share.
* Revenue rose 19.4% to $1.45 billion from a year ago;
analysts
expected $1.47 billion.
* agilon health inc's reported EPS for the quarter was a
loss
of 29 cents.
* The company reported a quarterly loss of $117.62 million.
* agilon health inc shares had fallen by 29.0% this
quarter and
lost 77.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 4.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 13
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "hold"
Wall Street's median 12-month price target for agilon health inc
is $6.25
This summary was machine generated from LSEG data November 8 at
05:11 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.11 -0.29 Missed
Jun. 30 2024 -0.08 -0.07 Beat
Mar. 31 2024 -0.01 -0.01 Met
Dec. 31 2023 -0.30 -0.41 Missed